Qinlock (ripretinib)

pCPA File Number: 21850

Negotiation Status:

Concluded with an LOI

Indication(s):

For the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with imatinib, sunitinib, and regorafenib

Sponsor/Manufacturer:

Medison Pharma Canada Inc.

CADTH Project Number:

PC0265

pCPA Engagement Letter Issued:

2022-07-12

Negotiation Process Concluded:

2023-05-12